title: Effects of hyperbaric oxygen on GDNF expression and apoptosis in spinal cord injury.
abstract: The effects of hyperbaric oxygen treatment on the progress of secondary damage following traumatic spinal cord injury were investigated. The early onset of hyperbaric oxygen treatment significantly diminished the number of apoptotic cells 1 day after the injury. However, hyperbaric oxygen did not influence the proliferation of macrophages or activated microglia. The gene expression of glial cell line-derived neurotrophic factor (GDNF) and inducible nitric oxide synthetase (iNOS) was significantly attenuated 1 day after the injury in the hyperbaric oxygen groups compared with the control group. The down-regulation was confirmed by immunohistochemical staining. Early hyperbaric oxygen treatment was shown to effectively suppress the progress of apoptosis perhaps via the inhibition of iNOS gene despite the down-regulation of the GDNF gene.
authors.affiliation: Department of Orthopaedic Surgery, Nagoya University School of Medicine, 466-8500 Nagoya, Japan. yuyimin@med.nagoya-u.ac.jp
authors.forename: Yimin
authors.initials: Y
authors.lastname: Yu
authors.forename: Yukihiro
authors.initials: Y
authors.lastname: Matsuyama
authors.forename: Makoto
authors.initials: M
authors.lastname: Yanase
authors.forename: Sachiko
authors.initials: S
authors.lastname: Ito
authors.forename: Kayo
authors.initials: K
authors.lastname: Adachi
authors.forename: Kotaro
authors.initials: K
authors.lastname: Satake
authors.forename: Noki
authors.initials: N
authors.lastname: Ishiguro
authors.forename: Kazutoshi
authors.initials: K
authors.lastname: Kiuchi
mesh_terms: D000818:Animals; D017209:Apoptosis; D002452:Cell Count / Q000379:methods; D005786:Gene Expression Regulation / Q000187:drug effects* / Q000502:physiology; D051100:Glial Cell Line-Derived Neurotrophic Factor; D006931:Hyperbaric Oxygenation / Q000379:methods; D007150:Immunohistochemistry / Q000379:methods; D020287:In Situ Nick-End Labeling / Q000379:methods; D008297:Male; D008565:Membrane Proteins / Q000235:genetics / Q000378:metabolism; D009414:Nerve Growth Factors / Q000235:genetics / Q000378:metabolism*; D019001:Nitric Oxide Synthase / Q000235:genetics / Q000378:metabolism; D052247:Nitric Oxide Synthase Type II; D010100:Oxygen / Q000494:pharmacology*; D012333:RNA, Messenger / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D020133:Reverse Transcriptase Polymerase Chain Reaction / Q000379:methods; D013119:Spinal Cord Injuries / Q000378:metabolism* / Q000473:pathology*; D013997:Time Factors
chemical_list: C495041:Gdnf protein, rat; D051100:Glial Cell Line-Derived Neurotrophic Factor; D008565:Membrane Proteins; D009414:Nerve Growth Factors; D012333:RNA, Messenger; D019001:Nitric Oxide Synthase; D052247:Nitric Oxide Synthase Type II; C496318:Nos2 protein, rat; D010100:Oxygen